MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-02-0001134
Vimal Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.99 Cr
▲ 55% YoY
Net profit · FY 2025
₹4.23 Cr
Net margin 5.5%
EBITDA · FY 2025
₹11.11 Cr
EBITDA margin 14.4%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹3.99 Cr
Issued & subscribed
Open charges
₹34.14 Cr
Satisfied ₹54.37 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
139
Provident fund records
About Vimal Drugs Private Limited
Data last updated:
Vimal Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2009PTC063551. Its GSTIN is 37AADCV0136A1ZW (Andhra Pradesh).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹3.99 Cr. It is led by directors including Venkata Ravi Kumar Vasireddy and Vasireddy Renuka Devi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at # 4B & 5B Sri Teja Residency Ravendra Society Kakatiya Hills Kavuri Hills Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.99 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹4.23 Cr (net margin 5.5%) and EBITDA of ₹11.11 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 26% over five years.
The company has about 139 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹34.14 Cr and satisfied charges of ₹54.37 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 1 case is pending.
Vimal Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0001134). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vimaldrugs.com.
Company details
CIN U24100TG2009PTC063551
Registration Number 063551
Incorporation Date 05 May 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0001134
CIN history
Vimal Drugs has one previous CIN (Corporate Identification Number): U24100AP2009PTC063551. The current CIN is U24100TG2009PTC063551, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2009PTC063551 | Current |
| U24100AP2009PTC063551 | Previous |
Key People
Venkata Ravi Kumar Vasireddy Director Vasireddy Renuka Devi Director Satish Mallela Additional Director Recognitions & Rankings of Vimal Drugs
Contact details
Vimal Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is vimaldrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address# 4B & 5B Sri Teja Residency Ravendra Society Kakatiya Hills Kavuri Hills Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vimal Drugs Private Limited, buy the company report.
Comprehensive company report
Vimal Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vimal Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vimal Drugs Private Limited, buy the company report.
Financials of Vimal Drugs Private Limited
FY 2024 filings availableVimal Drugs Private Limited reported revenue of ₹76.99 Cr (up 55% YoY) for FY 2025.
Revenue · FY 2025
₹76.99 Cr ▲ 55%
Net profit · FY 2025
₹4.23 Cr margin 5.5%
EBITDA · FY 2025
₹11.11 Cr margin 14.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 18%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 24%
5 years · compounded
▲ 76%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 55% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.4% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vimal Drugs Private Limited, buy the company report.
Board of directors of Vimal Drugs Private Limited
Vimal Drugs has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Ravi Kumar Vasireddy Also directs: Sr Generics Private Limited, A R Pharma Private Limited | Director | 21 Nov 2015 | 10 Years 11 Months | Current |
| Vasireddy Renuka Devi | Director | 17 Jan 2020 | 6 Years 9 Months | Current |
| Satish Mallela Also directs: A R Pharma Private Limited | Additional Director | 13 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Vimal Drugs Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clarion Organics Limited | ₹78.17 Cr (FY 2024) | 14.0% | Bhandara, Maharashtra, India | |||
| Pratap Organics Private Limited | ₹78.04 Cr (FY 2024) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Asence Pharma Private Limited | ₹77.56 Cr (FY 2025) | 19.0% | Vadodara, Gujarat, India | |||
| J P N Pharma Private Limited | ₹77.5 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Vimal Drugs Private Limitedthis company | ₹76.99 Cr (FY 2025) | ₹4.23 Cr | 5.5% | 55.0% | 139 | Hyderabad, Telangana, India |
| Vineet Laboratories Limited | ₹76.98 Cr (FY 2025) | -49.0% | Hyderabad, Telangana, India | |||
| Innovare Labs Private Limited | ₹76.64 Cr (FY 2024) | -8.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vimal Drugs Private Limited, buy the company report.
Auditor
Vimal Drugs Private Limited is audited by GUDURU SREENIVASA RAO AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUDURU SREENIVASA RAO AND CO | FY 2023 | 0025329S |
Shareholding
The shareholding of Vimal Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vimal Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹34.14 Cr
Satisfied charges
₹54.37 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2025 | 101081076 | Others | ₹78.28 Lakh | Open | |
| 29 Sep 2024 | 100981964 | Others | ₹33 Cr | Open | |
| 06 Jul 2024 | 100970244 | Hdfc Bank Limited | ₹30.07 Lakh | Open | |
| 03 Jan 2024 | 100905628 | Hdfc Bank Limited | ₹6 Lakh | Open | |
| 02 May 2025 | 101097770 | Others | ₹3.5 Cr | Satisfied |
To see the full charge records of Vimal Drugs Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Vimal Drugs Private Limited has 5 court cases on record: 1 filed by Vimal Drugs, 4 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed by the company
1
Filed against the company
4
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed against the company by Meenaakshi Molecules Pvt. Ltd. | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Ms Lee Pharma Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case SC) | Filed against the company by Mody Chemi Pharma | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Civil suit | Filed against the company by Ms Subham Safety Solutions | Disposed |
To see the full case history of Vimal Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vimal Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vimal Drugs Private Limited has a workforce of 139 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
139
Active EPFO establishments
1
Employee growth
26.36%
GST
Vimal Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCV0136A1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vimal Drugs Private Limited, buy the company report.
Recent activity
Vimal Drugs Private Limited has 21 board changes on record since 2012: 3 appointments and 18 cessations. The latest: Satish Mallela was appointed as Additional Director on 13 Apr 2021.
Charges
A charge registered on 02 May 2025 via Charge ID 101097770 with Others was fully satisfied on 05 Aug 2025.
Charges
A charge registered on 07 Feb 2024 via Charge ID 100863324 with Others was fully satisfied on 22 May 2025.
Charges
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 101097770 was registered on 02 May 2025.
Charges
A charge with Others amounted to Rs. 0.78 Cr with Charge ID 101081076 was registered on 28 Feb 2025.
AGM
Vimal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 33.00 Cr with Charge ID 100981964 was registered on 29 Sep 2024.
Charges
A charge registered on 01 Sep 2017 via Charge ID 100142085 with Hdfc Bank Limited was fully satisfied on 25 Sep 2024.
Charges
A charge registered on 10 May 2022 via Charge ID 100594693 with Others was fully satisfied on 30 Aug 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100970244 was registered on 06 Jul 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 35.67 Cr registered on 01 Sep 2017 with Charge ID 100142085 was modified on 12 Jun 2024.
Filing
Vimal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100863324 was registered on 07 Feb 2024.
28 earlier events are in the company report.
Frequently asked questions
Vimal Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2009 (17+ years old) and is registered under CIN U24100TG2009PTC063551.
Vimal Drugs has 3 current directors:
- Venkata Ravi Kumar Vasireddy - Director
- Vasireddy Renuka Devi - Director
- Satish Mallela - Additional Director
The latest financial statements of Vimal Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Vimal Drugs is 37AADCV0136A1ZW, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Vimal Drugs is U24100TG2009PTC063551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vimal Drugs has 5 court cases on record: 1 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.
Vimal Drugs was incorporated on 05 May 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vimal Drugs by revenue are Clarion Organics Limited, Pratap Organics Private Limited, Asence Pharma Private Limited, J P N Pharma Private Limited, Vineet Laboratories Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satish Mallela was appointed as Additional Director on 13 Apr 2021. Suneetha Cherukuru ceased to be Director on 17 Jan 2020. Vasireddy Renuka Devi was appointed as Director on 17 Jan 2020. Vimal Drugs has 21 board changes on record in total.
Yes, Vimal Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0001134).
Vimal Drugs can be reached through the website vimaldrugs.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages